XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Best Efforts Offering [Member]
Follow On Offering [Member]
At The Market Offering [Member]
Series B Convertible Preferred Stock
Series A Convertible Preferred Stock
Series C Convertible Preferred Stock
IPO [Member]
Common Stock [Member]
Common Stock [Member]
Best Efforts Offering [Member]
Common Stock [Member]
Follow On Offering [Member]
Common Stock [Member]
At The Market Offering [Member]
Common Stock [Member]
Class A Common Stock [Member]
Common Stock [Member]
Class B Common Stock
Common Stock [Member]
IPO [Member]
Subscription Receivable Preferred Stock Series A
Additional Paid In Capital
Additional Paid In Capital
Best Efforts Offering [Member]
Additional Paid In Capital
Follow On Offering [Member]
Additional Paid In Capital
At The Market Offering [Member]
Additional Paid In Capital
IPO [Member]
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2022 $ (2,733)                       $ 4       $ 112,436         $ 365 $ (115,538)
Beginning balance, shares at Dec. 31, 2022                         60,417 856                  
Issuance of stock 4,452               $ 3               4,449            
Issuance of stock, shares                 216,923                            
Issuance of Common stock upon conversion of Common Stock                 $ 4       $ (4)                    
Issuance of Common stock upon conversion of Common Stock, shares                 60,417       (60,417)                    
Issuance of Common stock upon exercise of stock options 14                               14            
Common stock converted, shares                 17,017         (17,017)                  
Issuance of Common stock upon exercise of stock options, shares                           16,161                  
Stock-based compensation 15,057                               15,057            
Net exercise of options 323                               323            
Foreign currency translation gain (loss) (115)                                         (115)  
Net Income (Loss) (15,961)                                           (15,961)
Ending balance at Mar. 31, 2023 1,037               $ 7               132,279         250 (131,499)
Ending balance, shares at Mar. 31, 2023                 294,357                            
Beginning balance at Dec. 31, 2022 (2,733)                       $ 4       112,436         365 (115,538)
Beginning balance, shares at Dec. 31, 2022                         60,417 856                  
Foreign currency translation gain (loss) (79)                                            
Ending balance at Sep. 30, 2023 (274)               $ 7               154,942         286 (155,509)
Ending balance, shares at Sep. 30, 2023                 354,463                            
Beginning balance at Mar. 31, 2023 1,037               $ 7               132,279         250 (131,499)
Beginning balance, shares at Mar. 31, 2023                 294,357                            
Issuance of stock               $ 10,820                         $ 10,820    
Issuance of stock, shares                             37,500                
Initial Public Offering Costs (4,607)                               (4,607)            
Issuance upon conversion of convertible notes, shares                 14,129                            
Exercise of stock warrants (in shares)                 8,477                            
Issuance of Common stock upon conversion of convertible notes 4,521                               4,521            
Exercise of stock warrants 2,468                               2,468            
Stock-based compensation 4,510                               4,510            
Foreign currency translation gain (loss) (136)                                         (136)  
Net Income (Loss) (13,602)                                           (13,602)
Ending balance at Jun. 30, 2023 5,011               $ 7               149,991         114 (145,101)
Ending balance, shares at Jun. 30, 2023                 354,463                            
Stock-based compensation 4,951                               4,951            
Foreign currency translation gain (loss) 172                                         172  
Net Income (Loss) (10,408)                                           (10,408)
Ending balance at Sep. 30, 2023 (274)               $ 7               154,942         286 (155,509)
Ending balance, shares at Sep. 30, 2023                 354,463                            
Beginning balance at Dec. 31, 2023 (5,552)               $ 7               161,252         100 (166,911)
Beginning balance, shares at Dec. 31, 2023                 354,802                            
Issuance of preferred stock Series upon conversion of debt, Shares           3,430,895                                  
Issuance of preferred stock Series upon conversion of debt 10,082         $ 1                     10,082            
Subscription receivable for issuance of Series A preferred stock, shares           1,500,000                                  
Subscription receivable for issuance of Series A preferred stock (3,000)                             $ (3,000)              
Issuance of preferred stock series B upon acquisition of CLMBR, Inc, Shares         1,500,000                                    
Issuance of preferred stock series B upon acquisition of CLMBR, Inc.         $ 2,688                                    
Issuance of common stock upon acquisition of CLMBR, Inc, Shares                 35,723                            
Issuance of common stock upon acquisition of CLMBR, Inc. 1,014               $ 0               1,014            
Issuance of Common stock upon waiver to enter into Note Agreement                 6,250                            
Issuance of Common stock upon waiver to enter into Note Agreement,Value 177               $ 0               177            
Issuance of shares upon issuance of convertible notes, shares                 18,750                            
Issuance of shares upon issuance of convertible notes 547               $ 0               547            
Issuance of common stock from equity line of credit                 32,777                            
Issuance of common stock from equity line of credit 692               $ 0               692            
Issuance upon conversion of convertible notes, shares                 37,149                            
Issuance of Common stock upon conversion of convertible notes 866               $ 0               866            
Issuance of Common stock upon exercise of stock options, shares                 394                            
Stock-based compensation 3,586                               3,586            
Foreign currency translation gain (loss) 39                                         39  
Net Income (Loss) (11,394)                                           (11,394)
Ending balance, shares at Mar. 31, 2024         1,500,000 4,930,895                                  
Endng balance at Mar. 31, 2024         $ 2,688 $ 1                                  
Ending balance at Mar. 31, 2024 (2,942)               $ 7             (3,000) 178,216         139 (178,305)
Ending balance, shares at Mar. 31, 2024                 485,845                            
Beginning balance at Dec. 31, 2023 (5,552)               $ 7               161,252         100 (166,911)
Beginning balance, shares at Dec. 31, 2023                 354,802                            
Issuance of stock, shares                 1,286,957                            
Foreign currency translation gain (loss) (205)                                            
Ending balance, shares at Sep. 30, 2024         1,500,000 5,368,865 2,861,128                                
Endng balance at Sep. 30, 2024         $ 0 $ 1 $ 0                                
Ending balance at Sep. 30, 2024 5,792               $ 8               202,509         (105) (196,621)
Ending balance, shares at Sep. 30, 2024                 17,170,456                            
Beginning balance at Mar. 31, 2024 (2,942)               $ 7             (3,000) 178,216         139 (178,305)
Beginning balance, shares at Mar. 31, 2024                 485,845                            
Issuance of stock     $ 809 $ 405             $ 0 $ 0             $ 809 $ 405      
Issuance of stock, shares                     142,046 162,378                      
Registered direct offering costs (74)                               (74)            
At the Market offering costs (50)                               (50)            
Issuance of preferred stock Series upon conversion of debt, Shares           1,562,970                                  
Issuance of preferred stock Series upon conversion of debt 2,368         $ 0                     2,368            
Subscription receivable for issuance of Series A preferred stock 3,000                             $ 3,000              
Issuance of common stock from equity line of credit                 7,918                            
Issuance of common stock from equity line of credit 65               $ 0               65            
Issuance upon conversion of convertible notes, shares                 251,084                            
Exercise of stock warrants (in shares)                 23,112                            
Issuance of Common stock upon conversion of convertible notes 1,084               $ 0               1,084            
Issuance of Common stock upon conversion of warrants, Shares           375,000                                  
Issuance of Common stock upon conversion of warrants 480         $ 0                     480            
Reclassification of series B preferred stock to permanent equity, Shares         (1,500,000)                                    
Reclassification of series B preferred stock to permanent equity         $ (2,688)                                    
Reclassification of series B preferred stock to permanent equity, Shares         1,500,000                                    
Reclassification of series B preferred stock to permanent equity 2,955       $ 0                       2,955            
1 for 40 reverse stock split share round up                 100,312                            
Exercise of stock warrants 92               $ 0               92            
Issuance of Common stock upon exercise of stock options, shares                 82                            
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture                 0                            
Stock-based compensation 2,860                               2,860            
Foreign currency translation gain (loss) (2)                                         (2)  
Net Income (Loss) (10,637)                                           (10,637)
Ending balance, shares at Jun. 30, 2024         1,500,000 6,868,865                                  
Endng balance at Jun. 30, 2024         $ 0 $ 1                                  
Ending balance at Jun. 30, 2024 413               $ 7               189,210         137 (188,942)
Ending balance, shares at Jun. 30, 2024                 1,172,777                            
Issuance of stock   $ 296   $ 3,669           $ 0   $ 1           $ 296   $ 3,668      
Issuance of stock, shares                   210,000   11,873,761                      
Best Efforts Offering Costs (16)                               (16)            
Series A Preferred dividends declared and paid in kind, shares           59,668                                  
Series A Preferred dividends declared and paid in kind                                 538           (538)
Issuance of preferred stock Series upon conversion of debt, Shares           (1,559,668) 2,861,128                                
Issuance of preferred stock Series upon conversion of debt 2,720           $ 0                   2,720            
Exercise of stock warrants (in shares)                 2,626,880                            
Exercise of stock warrants 2,563               $ 0               2,563            
Issuance of Common stock upon exercise of stock options, shares                 81                            
Issuance of Common stock upon extinguishment of debt, shares                 1,286,957                            
Issuance of Common stock upon extinguishment of debt 373               $ 0               373            
Stock-based compensation 3,157                               3,157            
Foreign currency translation gain (loss) (242)                                         (242)  
Net Income (Loss) (7,141)                                           (7,141)
Ending balance, shares at Sep. 30, 2024         1,500,000 5,368,865 2,861,128                                
Endng balance at Sep. 30, 2024         $ 0 $ 1 $ 0                                
Ending balance at Sep. 30, 2024 $ 5,792               $ 8               $ 202,509         $ (105) $ (196,621)
Ending balance, shares at Sep. 30, 2024                 17,170,456